Concepedia

Marion Chakiath

MC

Statistics

Publications

2

Citations

35

H-Index

2

Active since

2021

Affiliations

Precigen (United States)(Current)

Marion Chakiath is an author at Precigen (United States) specializing in higher-risk myelodysplastic syndromes, hematologic oncology, and chemotherapy.

Publications per year

2021–2023

2

Publications

2

Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

David A. Sallman, Hany Elmariah, Kendra Sweet et al. · Blood · 2021 · 24 citations

, , +15

Phase 1/1b study of PRGN-3005 autologous UltraCAR-T cells manufactured overnight for infusion next day to advanced stage platinum resistant ovarian cancer patients.

John B. Liao, Sasha E. Stanton, Marion Chakiath et al. · Journal of Clinical Oncology · 2023 · 11 citations

, , +17

1–2 of 2